CClinicalTrials.gg
CompletedNCT05007600Updated Aug 16, 2021

Online Interactive Courses on Loneliness and Quality of Life of Older Adults

An interventional study of Online Interactive Courses in Older Adults, sponsored by Yang Shang-Yu. Completed at 1 site in Taiwan. Open to participants aged 65 Years to 88 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-16.

Sponsored by Yang Shang-Yu · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Feb 2021, registered Aug 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
89
Allocation
Randomized
Ages
65 Years to 88 Years
Sex
All
01

Study summary

Background:

The early stage of the COVID-19 pandemic can be marked as a critical period in human history as it increased loneliness in people's lives. This is particularly true for the older adults who are single, living alone, and suffering from chronic diseases. However, there is insufficient existing research on associated interventions and their effectiveness.

Objectives:

To investigate the effectiveness of an 8-week online interactive course on the loneliness, depression, social support, and quality of life (QOL) of older adults in the community during the COVID-19 pandemic.

Methods:

This pilot study, also a single-blind randomized controlled trial, collected data from a community in central Taiwan. Participants were randomly divided into an experimental group and a control group. Subsequently, participants in the experimental group received an 8-week intensive (Monday to Friday) online interactive course, whereas those in the control group consumed 8 weeks of unidirectional online video and audio programs (such as from YouTube). Assessments were conducted both before and after the intervention, with the primary outcome being the UCLA Loneliness Scale (UCLA), and secondary outcomes being the Geriatric Depression Scale Short Form, the Inventory of Socially Supportive Behavior (ISSB) Scale, and the WHO Quality of Life-BREF (WHOQOL-BREF) Scale.

02

Conditions studied

  • Older Adults
03

In context

Lead sponsor

Yang Shang-Yu is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 88 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • (1) senior residents aged over 60 years, those who were not diagnosed with any cognitive impairment;
  • (2) capable of communicating in Mandarin or Taiwanese; and
  • (3) capable of using smartphones.

Exclusion criteria

Exclusion Criteria:

  • (1) participants who could not fully complete the 8-week intervention (or participate in the course for at least three days per week); and
  • (2) those who were incapable of understanding the content of the questionnaire.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
89 participants (actual)

Study arms

  • Experimental
    trial group

    Participants in the experimental group received an 8-week intensive (Monday to Friday) online interactive course.

    Other: Online Interactive Courses

  • No intervention
    Control group

    Participants in the control group consumed 8 weeks of unidirectional online video and audio programs (such as from YouTube).

Interventions

  • OtherOnline Interactive Courses

    In the experimental group, after consensus was reached in the expert meeting (consisting of a doctor specializing in occupational therapy, a doctor specializing in nursing, and a doctor specializing in public health), a 5-days-per-week (Monday to Friday) 8-week intensive online interactive course was designed. The course was made accessible to the participants through a social network app (Line) from 12:00 to 20:30.

06

What researchers measure

Primary outcomes

  1. UCLA Loneliness Scale (UCLA)

    The third version of UCLA compiled by Russel (1996) was used to measure "loneliness." It was translated into Chinese by Chang and Yang (1999) and included 20 questions. Each question was scored on the 4-point Likert Scale, with 1: "I never feel this way," 2: "I rarely feel this way," 3: "I sometimes feel this way," and 4: "I often feel this way." The total score ranged between 20 and 80, and the higher the score, the higher the participant's degree of loneliness. In this study, the Cronbach's alpha of the pre- and post-intervention UCLA was 0.76 and 0.78, respectively.

    Time frame: 10-20 minutes

Secondary outcomes

  1. Geriatric Depression Scale Short Form (GDS-SF)

    Developed by Sheikh and Yesavage (1986), GDS-SF comprises 15 Yes or No questions, with participants scoring 1 if answering "Yes" or 0 if answering "No." The 2-point scale (Yes/No) made the questionnaire easy to complete for the participants. The threshold of the scale was 7 points, with scores larger than 7 indicating a depression status. The total score ranged between 0 and 15, and the higher the score, the higher the degree of depression. In this study, the Cronbach's alpha of the pre- and post-intervention GDS-SF was 0.81 and 0.82, respectively.

    Time frame: 10-20 minutes

  2. Inventory of Socially Supportive Behavior (ISSB) Scale

    Initially developed by Barrera Jr et al. (1981), ISSB was subsequently translated into Chinese and compiled into 8 questions by Ou (2013). The scale consisted of two categories, namely Emotional Support and Tangible Support. The total score of both categories represented the participant's satisfaction with social support. The scale was scored on a 5-point Likert Scale, with 1 representing "Strongly disagree," 2: "Disagree," 3: "Neutral," 4: "Agree," and 5: "Strongly agree." The total score ranged between 8 and 40, and the higher the score, the higher the participant's satisfaction with social support. In this study, the Cronbach's alpha of the pre- and post-intervention ISSB was 0.83 and 0.77, respectively.

    Time frame: 10-20 minutes

  3. WHO Quality of Life-BREF (WHOQOL-BREF) Scale

    The questionnaire was composed of questions on QOL formulated by the World Health Organization (WHO) based on the commonality of various cultures. The Taiwanese version of WHOQOL-BREF included 28 questions, each scored on a 5-point Likert Scale. It was composed of four domains, namely, Physical health (7 questions), Psychological health (6 questions), Social relationships (4 questions), and Environment (9 questions). The score of an individual question ranged between 1 and 5, and after conversion, the total score of each domain ranged between 4 and 20. The higher the score, the higher the individual's QOL. In this study, the Cronbach's alpha of the domains Physical health, Psychological health, Social relationships, and Environment before and after the intervention was 0.82 (0.80), 0.77 (0.79), 0.76 (0.81), and 0.82 (0.84), respectively.

    Time frame: 10-20 minutes

07

Study locations

1 site
  • Asia Univeraity
    Taichung, WuFeng 41354, Taiwan
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 16, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05007600
Lead sponsor
Yang Shang-Yu
Responsible party
Yang Shang-Yu (Assistant professor, National Cheng Kung University) — Sponsor-investigator
First posted
Aug 16, 2021
Start date
Feb 1, 2021
Primary completion
Jul 1, 2021
Completion
Jul 30, 2021
Last update
Aug 16, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion